Kristian Ebbensgaard

Kristian Ebbensgaard is an experienced professional in the fields of biotechnology and business management. Currently serving as an Advisor and Director of the Pheromone Platform at FMC Corporation since January 2023, Kristian has previously held significant leadership roles, including CEO at BioPhero and Board Member at Alliance for Biosolutions. With a solid foundation in business from Copenhagen Business School and a degree in Biotechnology from DTU, Kristian has also contributed to Novozymes in various capacities, including Acquisition Director and Sales Director. Additional experience includes roles at Speednames Business and The Boston Consulting Group, along with military service as a First Lieutenant in the Danish Army. Currently pursuing a B.Sc. in Machine Learning and Data Science at the University of Copenhagen, Kristian combines technical expertise with strategic leadership in business innovation.